About Beamt
AI is rewriting what it means to build a software company. Beamt builds the tools that let one person prove it.
The founding moment
After 20 years building software in the MedTech industry — culminating in Medstrat’s acquisition by Zimmer Biomet — I decided I wanted more autonomy. The AI revolution had just changed what one person could ship. The moment to move was now.
I’d spent two decades operating under FDA-grade quality gates: every line of code traced to a specification, every change reviewed, every release audited. Discipline like that doesn’t come from headcount — it comes from the tools, the process, and the conviction to keep them. AI lets one person carry that discipline at the velocity that used to require a team.
I started Beamt to build the tools that make that real for everyone else.
The bet on solo founders
The marketplace has been reborn. AI lets a solo founder do more than ever before — write more code, ship more product, support more customers, generate more documentation. The work that used to require a team of twenty can be carried by one person with the right tools and the right judgment.
That changes who gets to build. The next wave of software companies will be founded by individuals with deep domain expertise who would never have raised a seed round to assemble a team. They’ll go directly from idea to product, sustained by a stack of AI-native tools that handle the parts that used to demand specialist hires.
I’m betting that wave creates a wealth of opportunities to build the services those founders need. Beamt is my answer to that bet.
The product arc
Beamt’s focus is to build a portfolio of products that, taken as a whole, let a solo founder be successful from day one.
Today that’s two products:
- Recupra stops silent revenue leakage from failed payments for solo founders on Stripe (available now).
- Talos forges new software and documents it in plain English (Q2 2026 early access).
More will follow. Each product in the portfolio will share the same Beamt principles: usage-based or flat pricing (never percentage-of-recovered, never per-seat), AI-agnostic where it matters, regulated-software discipline applied to consumer-grade SaaS economics.
My path
Medstrat was an FDA-approved medical imaging platform serving 25%+ of US orthopedic practices. We reached $10M ARR before Zimmer Biomet (Fortune 500) acquired the company. As CTO, I owned the engineering side of that journey end-to-end — architecture, regulatory readiness, deployment, and the quality system that made every release defensible to an auditor.
Twenty years of writing software that runs in operating rooms and passes FDA audits taught me a few things you don’t pick up shipping consumer SaaS. Specs are contracts, not suggestions. Tests are evidence, not insurance. Documentation is deliverable, not afterthought. Every shortcut you take today is a finding in tomorrow’s audit.
I’m bringing that discipline to Beamt — and to the products Beamt builds. Recupra’s payment-data architecture is closer to a HIPAA system than to a typical Stripe integration. Talos generates Gherkin documentation alongside code because regulated software taught me that what you built and what you said you built had better match.
More about me at smethells.com →The AI revolution is happening — fast. Beamt will help answer some, many, or all of the needs of the solo founders building through it.